Psychedelic News

Hawaii’s Senate unanimously voted to establish a working group to ensure the safety, accessibility, and affordability of psilocybin.

Interview With Dr. Joseph Tucker

MagicMed Industries’ CEO, Dr. Joseph Tucker, talks about their psychedelic library, the company’s plans to go public and what the future of psychedelic research looks like.

Interview With Dustin Robinson

Mr. Psychedelic Law’s Co-Founding Partner, Dustin Robinson, talks about how he became involved with the medicinal psychedelic space.

Study Investigates Optimal Dosing for MDMA

Potential optimal MDMA dosages for therapeutic benefit and reduced adverse events were investigated in a new study published in the latest edition of the Journal of Psychopharmacology.

A Third Massachusetts City Just Decriminalized Psychedelics

Policy, Uncategorized

Following Somerville and Cambridge, Northampton, Massachusetts, is the latest city to decriminalize certain psychedelics.

Psychedelic Business News Spotlight: April 2, 2021

This week in psychedelic business news: cannabis dives in, ketamine delivery, and psilocybin for autism anxiety.

How Field Trip Health Is Leading the Psychedelic Market Boom

Field Trip Health is brining psychedelics to the forefront of mental health wellness.

UCSF Launches New Psychedelic Research Division

Psychedelic research is coming to the University of California in a new division to study MDMA.

Mass General to Study Psilocybin at New Psychedelic Research Center

Massachusetts General Hospital has launched a new center for psychedelic research. First up: the benefits of psilocybin.

Meditation and Psychedelics Have Similar Effects On Our Brains: Do We Need Both?

Culture, Research

The synergy between meditation and psychedelics has been long understood. Now, as research explores the benefits, do we need both?

Interview With Nick Levich

Psychedelic Passage’s Co-Founder and Facilitator, Nick Levich, talks about the function, purpose and importance of a trip sitter during a psychedelic experience.

Interview With Pierre Bouchard

Psychotherapist, Pierre Bouchard talks with our Director of Content, Jill Ettinger.

Use of Psychedelic Shows Correlation With Better Overall Physical Health

Use of Psychedelics Show Correlation With Better Overall Physical Health

Do psychedelics improve health? A new study finds a correlation between user health and psychedelic experiences.

Are Stereotypes Around Psychedelics Slowing Down Research?

Psychedelics come with history as party drugs. Are these stigmas slowing down progress?

Minnesota Gets Its First Psychedelic Medicine Clinic

The first psychedelic therapy clinic has opened in Minnesota. The Institute for Integrative Therapies will provide ketamine-assisted therapy.

Listening to Ecstasy: Can This Man Normalize MDMA for Seniors?

New Research Investigates Psilocybin as OCD Treatment

Researchers are looking at how psilocybin and other psychedelics may help with OCD (obsessive-compulsive disorder).

New Guidance Released for Ketamine, Esketamine Therapy Use

Suggested guidances for use of ketamine and esketamine therapy have been published in the American Journal of Psychiatry.

Psychedelic Use Linked to 20% Decreased Hypertension Risk, Study Finds

Psychedelic use may help to decrease the risk of hypertension, according to new research.

Psychedelic Business News Spotlight: March 26, 2021

This week in psychedelic business news sees pharmaceutical giant Merck enter the arena, psilocybin research, and more.

New Study Finds Possible Mechanism for Psilocybin’s Anti-Depressive Effects

Scientists are closer to unraveling the mystery behind the psilocybin effects and its ability to offer anti-depressive benefits.

MAPS Founder Rick Doblin Discusses MDMA Research for PTSD With Actress Mayim Bialik

Culture, Research

Rick Doblin, the founder of MAPS, joined actress Mayim Bialik's podcast Breakdown to discuss MDMA and PTSD research.

University of Wisconsin Opens Country’s First Master’s in Psychedelic Medicine

The University of Wisconsin is the first in the U.S. to offer a master's degree in development of psychedelic medicine.

Interview With Dr. Steven Mandel

In this episode of the Psychedelic Spotlight podcast, we have the distinct privilege of speaking with one of the foremost experts in ketamine-assisted therapy, Dr. Steven L. Mandel, Founder and President of Ketamine Clinics Los Angeles.

Interview With Sacha Hebbert

Mind Cure Health's Senior Product and Marketing Manager, Sacha Hebbert, talks about the company's recent launch of its product sales division.

Former Presidential Candidate Andrew Yang Wants to Decriminalize Psilocybin Mushrooms

Culture, Policy

Former presidential candidate Andrew Yang wants to decriminalize psilocybin. And if he becomes mayor of New York City, that could happen.

Big Pharma Giant Merck Partners With Psychedelic Research Company Novamind

Pharmaceutical giant Merck is partnering with psychedelic research company Novamind to test a possible therapy for treatment-resistant depression.

Women Are More Likely to Use Psychedelics Than Men

Survey: Women Use Psychedelics More Often Than Men

A new survey finds women are more likely to self-treat with psychedelics than men, particularly for issues including depression and trauma.

Australia to Study Psilocybin for Meth Addiction

New psychedelic research underway in Australia will look at the success of treating meth addiction with psilocybin.

Can Psilocybin Cure Obesity? NeonMind Biosciences Thinks It Just Might

Can psilocybin help cure obesity? NeonMind Biosciences is hopeful. The company is researching the benefits of psychedelics for eating disorders.

Advocacy Group Launches Campaign to Legalize Psychedelics in Michigan

Michigan could follow in the steps of Oregon to legalize psychedelics for therapeutic use. Ann Arbor already decriminalizes possession.

Psychedelic Business News Spotlight: March 19, 2021

This week in psychedelic business news, quick dissolve LSD, novel psychedelic molecules move into investigational studies, and more.

These 24 Psychedelic Patents Are Paving the Way for Medicine 2.0

Business, Research

Patents of psychedelic substances are paving the way for new research and treatment options for a variety of diseases.

Establishing the Ethical Imperative in Psychedelic Medicine

Researchers to Hone In On Most Therapeutic Doses of LSD

New research is looking into the optimal dose of LSD to further enhance the therapeutic benefits of the psychedelic.

Oregon’s Democratic Party Endorses Legalization of Psilocybin

Oregon Announces Creation of the Psilocybin Advisory Board

The first state to legalize therapeutic use of psilocybin, Oregon now has an advisory board to help build its regulations.

Psychotherapist Kelli Foulkrod Takes a Holistic Approach to Trauma Treatment With Psychedelics

Psychotherapist Kelli Foulkrod uses psychedelics with her patients as part of her holistic treatment to mental health issues.

New York Bill Would Decriminalize Psychedelics

New York Bill Would Decriminalize Psilocybin

Proposed legislation in the state of New York would decriminalize psilocybin, the psychedelic compound in some types of mushrooms.

How The Conscious Fund Is Changing Perceptions About Psychedelics

UK venture capital fund The Conscious Fund is working to make psychedelics more accessible and functional in various capacities.

Wshington DC Psychedelic Decriminalization

Psychedelics Officially Decriminalized In Washington D.C.

After voters approved a measure that decriminalized psychedelics in Washington D.C. last November, the measure is now in effect.

Interview With Joël Brierre

In this episode of the Psychedelic Spotlight podcast we speak with Joël Brierre who is the founder & CEO of Kaivalya Kollectiv.

Ketamine Retreats Focus on Healing Power of Nature

Silo Wellness Ketamine Retreats to Focus on Healing Power of Nature

Silo Wellness Inc., a wellness company in the psychedelics and functional mushroom space, is offering ketamine-assisted psychedelics wellness retreats

U.K. Psychedelic R&D Company Investigates MDMA, Ketamine for Addiction

Awakn Life Sciences is looking at psychedelics for addiction, namely MDMA and ketamine for alcohol use disorder.

Small Pharma Clinical Trials to Study DMT for Treatment-Resistant Depression

Small Pharma is going into clinical trials to look at DMT for depression relief. The UK company says it believes benefits will be immediate.

Vermont Bill Would Decriminalize Psychedelics In Interest of Public Health

Vermont is looking to decriminalize psychedelics as part of its efforts to improve public health in the state.

Silo Wellness to Launch a Bob Marley-Labeled Line of Psilocybin Mushrooms

The family of Bob Marley and Silo Wellness have teamed up for the first line of commercial psilocybin mushrooms.

Interview With Richard Skaife

In this episode of the Psychedelic Spotlight podcast we speak with Richard Skaife who is the Co-Founding Partner of The Conscious Fund.

Psychedelic Business News Spotlight: March 12, 2021

This week in psychedelic business news, Canada expands legal distribution for psychedelics, therapeutic DMT stroke treatment, and more.

Are the Subjective Effects of Psychedelics Necessary for Therapy?

Are the subjective effects - that is, the psychedelic trip itself - fundamental for therapeutic outcomes? New research explores.

Canada Expands Psychedelic Approvals for Numinus

Numinus Biosciences has received expanded regulatory approval in Canada for psychedelic use and distribution.

Algernon to Investigate DMT Microdose for Stroke Treatment

Algernon Pharmaceuticals is exploring the little-researched psychedelic substance DMT to see if it has potential in treating stroke patients.

Ketamine Therapy May Help Slow Progression of ALS

New research is looking at ketamine therapy as a potential aid in slowing the deadly disease ALS, amyotrophic lateral sclerosis.

Core One Labs and Ketamine Infusion Centers to Explore DMT Therapy for Anxiety and Depression

Core One Labs is exploring DMT therapy for anxiety and depression in a partnership with Ketamine Infusion Centers.

Beckley Psytech Explores Psilocybin for Headache Treatment

A new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting unilateral neuralgiform headache attacks.

In this episode, we chat with David Harder, the Co-Founder and CEO of ATMA Journey Centers, about their new healing and training space.

Atma Journey Centers Opens First Clinic In Calgary, Alberta

In this episode, we chat with David Harder, the Co-Founder and CEO of ATMA Journey Centers, about their new healing and training space.

Canada’s First End of Life Psilocybin Treatment Brought Peace to Terminal Man

Tony White may have lost his battle with cancer, but becoming the first end of life recipient of psilocybin treatment has changed everything.

Are ‘Magic’ Psilocybin Truffles the Fountain of Youth? New Study Looks at Anti-Aging Benefits

New research is looking at psilocybin truffles as a potential anti-aging tool and aid in treating age-related psychiatric disorders.

North America Is Poised to Take the Lead In Emerging Psychedelic Drug Market

North America Is Poised to Take the Lead In Emerging Psychedelic Drugs Market

Business, Policy

The psychedelic drugs market is finding a strong base in North America, according to new data. The U.S. and Canada in particular are supporting its expansion.

New App Creates Psychedelic Experience Without the Need for Substances

Can An App Give You a Psychedelic Experience Without Taking Drugs? Lumenate Says Yes

Business, Culture

Lumenate is an app that simulates a psychedelic experience without the need for illegal substances.

Minority Veterans Organization Urges Congress to Loosen Restrictions on Psychedelic Therapies

A minority veterans organization wants access to psychedelic therapies for PTSD and depression. It's urging Congress to take action.

Are Microdosing Benefits Real? A New Study Says It May All Be In Your Mind

MIcrodosing with psychedelics is gaining in popularity but new research says the placebo effect worked just as well.

Defiance Just Launched the World's Second Psychedelic-Focused ETF

Defiance Just Launched the World’s Second Psychedelics-Focused ETF

Defiance has launched the world's second psychedelics-focused ETF as investing in psychedelic therapy and treatment accelerates.

Missouri Bill Would Give Terminally Ill Patients Access to Psychedelic Therapies

Policy, Treatment

Missouri residents with terminal or debilitating conditions may soon be able to access psychedelics under a new bill.

What are Psilocybin Truffles? Are They Safe?

Mushrooms have garnered plenty of attention for their psychedelic properties. Now the mushroom's ts lesser-known cousin, psilocybin truffles is in the spotlight.

How Do Hallucinogens Work? The Complete Guide to Psychedelic Benefits

Whether trying psychedelics recreationally or clinically, you may wonder: just how do hallucinogens work? Here's the guide to what to expect.

Psychedelic Business News Spotlight: March 5, 2021

This week in psychedelic business news: two companies enter the Canadian Stock Exchange, AI comes to psychedelic treatment, and psilocybin comes to Brazil.

Psychedelic Biotech Company Atai Life Sciences Valued At $2 Billion

Biotech company Atai Life Sciences has earned a $2 billion valuation for its work in developing psychedelic treatments for mental health issues.

Michael Pollan Explores More Psychedelics In New Book: This Is Your Mind on Plants

New York Times bestselling author Michael Pollan explores mescaline, opium, and caffeine in his forthcoming book "This Is Your Mind on Plants".

Ask a Psychotherapist With Kelli Foulkrod

We debut our first ever "Ask a Psychotherapist" segment where we take questions submitted by our listeners and have Kelli Foulkrod, a transpersonal psychotherapist, answer them.

UFC Explores Psychedelic Therapy for Brain-Injured Fighters

UFC is exploring psychedelic therapy for helping its fighters with brain injuries overcome the short and long-term issues.

Former UFC Fighter Ian McCall’s Reeducation on Psychedelics Comes With a Puppet Show

It's been nearly 3 years since Ian McCall stopped UFC fighting. Now, he's bringing psychedelics mainstream with the help of puppets.

Psychedelic Business News Spotlight: February 26, 2021

This week in psychedelic business news, Field Trip upsizes its bought deal, psilocybin truffles head to Brazil, another company goes public, and more.

First Of Its Kind $10 Million Psychedelic Research Center Comes to NYU

‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYU

Business, Research

NYU will open a $10 million psychedelic research center to further its work in using psychedelic substances to treat mental health issues.

How Music Plays a Role In Psychedelic Experiences

Should You Listen to Music During Psychedelic Treatments? How Sounds Impact the Experience

Does listening to music under the influence of psychedelics impact the experience? Here's what you need to know.

Interview With Christi Myers

In this episode of the Psychedelic Spotlight Podcast, our Director of Content catches up with Christi Myers, founder and director of Flow Wellness. Christi discusses her career as a paramedic and how that translates into her work now, helping people heal traumas with ketamine therapy.

Interview With Ronan Levy

In this episode of the Psychedelic Spotlight podcast, we catch up with Ronan Levy, Co-Founder and Executive Chairman of Field Trip Health, and discuss the significance behind the company’s recent opening of its psilocybin research and cultivation facility in Jamaica along with the company’s recent listing on the OTCQX.

So, You Want to Take Ibogaine: Here’s What You Need to Know About Treatment

Ibogaine treatment can help with a number of conditions including addiction. But where should you go? Are all centers safe? Here's what you need to know.

The Benefits of Mescaline: How An Ancient Cactus Became a Future Medicine

The benefits of Mescaline run the gamut. Over the centuries it's been revered for its psychedelic spiritual effects and that may make it a valuable too for the future.

Psychedelic Business News Spotlight: February 19, 2021

This week in psychedelic business news: MindMed acquires a digital health company, Mindest Pharma goes public, new MDMA treatment for PTSD, and more.

Interview With Payton Nyquvest

In this episode of the Psychedelic Spotlight podcast, Global Trac Solutions, Inc. CEO, David Flores, sits down with Payton Nyquvest, CEO and Chairman of Numinus Wellness, Inc.

Charley Wininger Hopes to Normalize MDMA With New Book ‘Listening to Ecstasy’

In his book 'Listening to Ecstasy' psychoanalyst and mental health counselor Charley Wininger discusses MDMA's benefits, including in his own marriage.

John C. Lilly: Father of LSD In the Sensory Deprivation Tank

John C. Lilly brought sensory deprivation tanks to the masses. He was also the first to bring LSD into the tanks. Do you know his story?

What Is Peyote? Everything You Need to Know About Mescaline Cactus

What is peyote? Here's everything you need to know about the psychedelic mescaline-rich cactus native to Mexico.

Psychedelic Business News Spotlight: February 12, 2021

This week in Psychedelic business news: MindMed has a new partner, Mydecine closes a funding round, and the world’s first legal psilocybin cultivation facility launches.

Study: 69% of Suicidal Patients Saw ‘Significant’ Improvement With Ketamine Therapy

A new study links ketamine therapy to a significant reduction in thoughts of suicide for 69 percent of study participants.

Interview With Carlos Tanner

In this episode, Global Trac Solutions, Inc. CEO, David Flores, has the very distinct pleasure of being joined by Carlos Tanner, founder of the Ayahuasca Foundation in Iquitos, Peru.

Why Ayahuasca Is Miley Cyrus’ ‘Favorite’ Drug

Singer Miley Cyrus says she's not likely to do it again, but ayahuasca is one of her favorite experiences. Find out what this psychedelic did for her.

New Research Finds Significant Role of Expectations in Psychedelic Microdosing Benefits

Are the benefits of psychedelic microdosing all in our heads? A new study looks at the results compared to placebo. The results might shock you.

Psychedelic Business News Spotlight: February 5, 2021

This week in psychedelic business news, Super Mario's magic mushroom gets a new use, Mindset files three patents, Bright Minds goes public, and more.

2 Massachusetts Cities Have Decriminalized Psychedelics in the Last Month

Two Massachusetts cities have decriminalized psychedelics since the start of 2021. Cambridge and Somerville say the benefits outweigh the risks.

Interview With Dr. Hyder A. Khoja

In this episode, Global Trac Solution's CEO, David Flores, sits down with Dr. Hyder A. Khoja to learn more about the work they're doing at Transcendent Therapeutics Inc.

Interview With Yaron Conforti, Novamind

In this episode, Psychedelic Spotlights, Director of Content, Jill Ettinger sits down with Chief Executive Officer, Director, and Co-Founder of Novamind, Yaron Conforti.

5-MeO-DMT: Can ‘Toad Juice’ Cure Depression?

Business, Research, Treatment

Clinical trials will look at the benefits of 5-MEO DMT as a treatment for relief from a number of mental health issues including depression.

The World’s First Psychedelic ETF Just Launched: Here’s Why That Matters

The Horizons Psychedelic ETF launched on the Canadian NEO stock exchange last month. Here's what that means for the industry, and the future.

How Red Light Holland Is Bringing Psilocybin Truffles Mainstream

Business, Treatment

Canada's Red Light Holland is preparing to take its psilocybin truffles global as demand for psychedelics heats up.

Psychedelic Business News Spotlight: January 29, 2021

This week in psychedelic business news, Psyence Group's psilocybin harvest, NeonMind's new CEO, and Mydecine sponsors new research.

Hawaii Moves to Legalize Psilocybin Treatment

Hawaii may soon legalize psilocybin therapy for the treatment of a range of mental health issues, according to proposed legislation.

Are Psychedelics the Secret for Coma Patients? Why This Doctor Thinks They Might Be

Should coma patients be given psychedelics? Dr. Hyder Khoja thinks they could be the best weapon in helping comatose people wake.

Interview With Josh Bartch, Mydecine Innovations Group

Global Trac Solutions, Inc. CEO, David Flores sits down to speak with Co-Founder & CEO, of Mydecine Innovations Group, Josh Bartch.

Canada Moves Closer Toward Legalizing Psychedelics

Policy, Treatment

Canada is stepping toward legalization of psychedelics to aid in treating mental health issues.

Psychedelic Business News Spotlight: January 22, 2021

This week in psychedelic industry news: the first psychedelic stock index, new products, mergers, and funds.

Daniel Carcillo’s Wesana Health Raises $4 Million to Expand Psychedelic Research

Business, Treatment

Wesana Health, founded by former NHL star Daniel Carcillo, has raised $4 million to continue its psychedelic research for traumatic brain injuries.

Interview With Henri Sant-Cassia, The Conscious Fund

Global Trac Solutions, Inc. CEO, David Flores sits down to speak with Co-Founding Partner at The Conscious Fund, Henri Sant-Cassia.

Can Ketamine Shake Its Bad Rap?

Ketamine has a history as a date rape drug. As it becomes a therapy for depression, can it shake its bad rap?

How Psychedelics Helped Shape Modern Technology

Psychedelics played a crucial role in technology as we know it, and they're playing a part in how it develops into the future, too.

Psychedelic Business News Spotlight: January 15, 2021

This week in psychedelic business news, IPOs, employee stock options, mergers, research, and more.

Interview With David Dardashti, Founder of Ibogaine clinic

David Dardashti talks about his Ibogaine clinic in Mexico, where he’s treated more than 8,500 people from trauma, addiction, and health issues.

Is America Ready for Psilocybin Mushroom Retreats?

With Oregon's recent victory for psychedelics, psilocybin retreats could soon be commonplace. What does that mean for mental health treatment?

What Are K-Holes? The Ketamine Experience Explained

What are k-holes? These ketamine-induced experiences can be life-changing for people suffering from depression.

Interview With Tim Moore, CEO of Havn Life

Tim Moore, CEO of Havn Life discusses how he is leveraging his past experience in the cannabis industry to create an effective path to success for Havn Life.

What Are Psilocybin Spores? Everything You Need to Know and Grow

What exactly are psilocybin mushroom spores? Are they legal? Here's everything you need to know and how to grow your own.

Psychedelic Business News Spotlight: January 08, 2021

This week in psychedelic business news, Mydecine, Neon Mind, Ehave, and more.

Interview With Kelsey Ramsden, President and CEO of Mind Cure

Kelsey Ramsden, the President, and CEO of Mind Cure Health Inc. sheds light on the advancements Mind Cure is currently making.

Could Psilocybin End Our Addiction Crisis?

Psilocybin is showing potential in addressing the alcoholism and addiction crises, new data find.

NeonMind Takes Psilocybin Therapy Public

NeonMind is the latest psychedelic company to go public. It's the first to launch on the Canadian Stock Exchange in 2021.

These 5 Apps Are Made for Taking Psychedelics

Business, Culture

Taking psychedelics? There's an app for that. These companies are leading the way with trip guides, support, and more.

Psychedelics Cause Ego Death: What You Need to Know

Culture, Research

One aspect of the psychedelic experience is something called ego death. Can it help people with mental health issues?

7 Psychedelic Trend Predictions for 2021

The momentum for psychedelics is snowballing, and 2021 is expected to be an even bigger and better year for the industry.

5 Athletes Who Healed With Psychedelic Therapy

Some of the world's top athletes have used psychedelic therapy to overcome addiction, depression, and other mental health issues.

Santa Claus Was a Psychedelic Mushroom

Was Santa Claus actually a psychedelic mushroom?

How Psychedelics Can Transform Your Sex Life

High, drunk, or sober, what’s your favorite way to have sex? asks the comedian Deon Cole during a recent Netflix Is A Joke special. As the crowd advocate for high or drunk, Cole reveals his intentions: if you can’t…

Psychedelic Business News Spotlight: December 17, 2020

The UK gets its first psychedelic VC fund, psychedelic treatment for Parkinson's, and more business news.

Interview with Daniel Carcillo

Professor Michiel van Elk Awarded More Than $970,000 Grant to Study Psychedelics

Professor Michiel van Elk of the University of Leiden has been awarded a nearly $1 million to study psychedelics.

New Synthetic Ibogaine Treats Addiction With Fewer Side Effects

A new version of synthetic ibogaine can treat opioid addiction but with a decreased risk of cardiac arrhythmias.

First-Ever DMT Trials for Depression Approved in UK

The UK will begin the first DMT trials for depression after Imperial College received approval to test the psychedelic.

Psychedelic Business News Spotlight: December 10, 2020

This week in psychedelic business news: Motley Fool bets on MindMed, mushrooms go from Jamaica to Canada, and more.

Interview with Kelli Foulkrod

Psychedelic Life Science Company Cybin Acquires Ketamine Drug Maker Adelia Therapeutics

Cybin Inc., has acquired the ketamine drug Spravato manufacturer Adelia Therapeutics in its first major acquisition.

Adele LaFrance: Healing Eating Disorders With Psychedelics

Clinical psychologist Adele LaFrance is working with psychedelics like ayahuasca to help treat eating disorders.

Interview with Ian McCall

The Artist’s Muse: Do Psychedelics Boost Creativity?

From 1954 to 1962, Oscar Janiger, an esteemed psychiatrist, invited 100 artists to his therapy room in downtown LA. Over the 10 hour sessions, the artists were provided with paper, a box of art materials, and 100 micrograms of LSD. Inspired…

Interview with Hadas Alterman

Psychedelic Business News Spotlight: December 3, 2020

This week in psychedelic business news: Numimus Wellness Inc. annouces a major partnership, Field Trip expands its investor relations, serial entrepreneur Peter Thiel invests in psychedelics for mental health treatment, and more. Numimus…

Interview with Amber Amendola

Psychedelics and Schizophrenia: What’s the Link?

Can psychedelics help treat schizophrenia? LSD-25 sat on a shelf for five years before Swiss chemist Albert Hofmann decided to reopen research on this strange chemical. One day while at work at Sandoz Laboratories, he accidentally let LSD…

Mike Tyson Credits 5-MeO for His Return to Boxing

The outspoken former undisputed heavyweight boxing champion Mike Tyson, now 54, says an experience with the potent psychedelic 5-MeO-DMT sparked his return to the ring this past holiday weekend. The exhibition fight against Roy Jones Jr.…

Why Is DMT Called The Spirit Molecule?

Why is DMT called “the spirit molecule?” Rick Strassman was the first American researcher to receive government approval to study hallucinogens after a two-decade ban. Between the years of 1990-95, the clinical associate professor…

Peter Thiel Invests $12 Million In Psychedelic Drug Manufacturer

Billionaire tech investor Peter Thiel is the latest to join the booming psychedelic industry. The PayPal co-founder backed Berlin’s ATAI Life Sciences in a $125 million series C funding round. Thiel’s investment firm, Thiel Capital,…

World’s First Psychedelic Psychotherapy Clinic to Open in January

The world’s first psychedelic-assisted therapy clinic of its kind is set to open its doors in the UK. AWAKN uses Ketamine, MDMA, and psilocybin alongside psychotherapy to treat mental health disorders. Run by Dr. Ben Sessa, AWAKN was formerly…

Inside the Underground World of Online Psychedelic Support Groups

It was 20 years ago and some of Mike’s friends had just come into a stash of some very special fungi. He hadn’t tripped on ‘shrooms before, and didn’t want to fly without doing some research into what the trip might be like. So, he…

Ready to Become a Mushroom Master?

Mushrooms are having a moment. From sustainable replacements for meat and leather to holding great potential in rewriting mental health treatments, there’s a ‘shroom boom fully underway. And leading the mycophilia revolution this week…

How Ibogaine Treatment Could Wipe Out Opioid Addiction

Ibogaine treatment facilities are popping up all around the world offering those addicted to opioids hope at long-lasting recovery without enduring painful withdrawal. Yet, the therapy is outlawed in the United States, a country in the throes…

21 Publicly-Traded Psychedelic Stocks Investors Have Their Eyes On

Thinking about investing in psychedelics? Experts say it could be a smart move. Researchers have been exploring the benefits of psychedelics for decades. And the research is showing promise; these substances appear to treat a number of…

California Moves to Legalize Psychedelics

California may move to decriminalize psychedelics following the victories in Oregon and Washington D.C. last November.

Allison Feduccia: Breaking Down Barriers to Psychedelic Medicine

“Career suicide!” That’s what Allison Feduccia’s graduate advisor told her when she told her in 2009 she wanted to use her PhD to explore the therapeutic possibilities of psychedelic medicine. “She was like, ‘Are you sure?…

Psychedelics Win Big at the Ballot Box

In one of the most contentious elections in modern history, one clear winner emerged at the ballot box: drugs. Regardless of political affiliation, citizens of Arizona, Montana, New Jersey, and South Dakota—two red and two blue states—legalized…

Psilocybin Four Times More Effective Than Antidepressants, Study Finds

New research into the benefits of psilocybin point to significant improvements for those suffering with depression. The new study, published in the journal JAMA Psychiatry found the impact of psilocybin was “more than four…

Can Psychedelics Help Treat Eating Disorders?

Psychedelics have been touted for their untapped therapeutic potential. Recent clinical trials have shown that they can help treat depression, OCD, alcoholism, and even help to kick the habit. Now, a new study released from Imperial…

Oregon Becomes the First U.S. State to Legalize Psilocybin

In an expected win for the nascent psychedelics industry, Oregon voters passed Measure 29 last night, legalizing the supervised use of psilocybin for medicinal purposes. The Measure passed by a 56.1 percent vote, bringing victory to the…

Washington D.C. Votes In Favor of Psychedelics

Residents in Washington D.C. have voted to decriminalize psychedelic substances including psilocybin. The measure, Initiative 81, is also known as the Entheogenic Plant and Fungus Policy Act of 2020. As polls closed Tuesday evening,…

What Is Ketamine Therapy?

In March 2019 the FDA approved ketamine, under the trade name Spravato (esketamine), for clinical use in treatment-resistant depression therapy. This is the first hallucinogen approved for therapeutic usage in the United States. Technically,…

Interview with Paul F. Austin

Interview with Mike “Zappy” Zapolin

Are Psychedelics the Most Cost-Effective Way to Treat Mental Health Issues?

Psychedelics are proving to be effective alternatives to conventional drug treatments for mental health issues. And they may be more cost-effective, too. This combination could change mental health care as we know it. According to data from…

The Healing Power of Ayahuasca: An Ancient Medicine for Modern Times

People say Mother Ayahuasca calls you when you’re ready. Her voice begins as an intuitive whisper. It reaches a crescendo until you finally take notice and come to her. And when you do, she does her magic and your life is changed forever. That’s…

Microdosing Results In Mental Health Benefits for 79% Of Users: Survey

A new study links microdosing psychedelics to improved mental health in the vast majority of subjects. Microdosing involves taking small amounts of substances such as LSD or psilocybin over an extended period of time. The low-level dosages…

Journey Colab Raises $3 Million for Mescaline Therapy

Journey Colab, a platform developing a pipeline for psychedelic therapy, has announced $3 million in funding. The funding comes from Apollo Project, founded by Sam Altman, the former Y Combinator president. The platform, which he runs with…

Psychedelics and Neuroplasticity: Molding a New Way of Thinking

Can psychedelics improve neuroplasticity in the brain? Psychedelics are making a comeback. Over the past decade we have seen some unprecedented results in modern psychiatry. From psilocybin treating depression, to LSD treating alcoholism.…

Psychedelics and Depression: What You Need to Know

Depression and psychedelics? Do they go together? Depression rates are spiking. Here’s how psychedelics may help. While seasonal depression is a reality for millions of people, this year is unique due to the pandemic. More than…

Are You a Good Candidate for a Psychedelic Study?

Could you be a candidate for taking part in a psychedelic study? What impact could it have on your mental health? Clinical studies are crucial to medical knowledge. They help researchers obtain valuable information about the safety…

Psychedelic Tech Company Cybin Brings In a $45 Million (CAD) Funding Round

Canadian pharmaceutical therapies company Cybin announced $45 million (CAD) in gross proceeds on a private placement of 60,000,000 subscription receipts as part of a new funding round. The company will use the funds to further expand its development…

Opioid Addiction Ibogaine Treatment Centers Could Soon Be Coming to Canada

Obtaining treatment for opioid addiction in specialized psychedelics clinics could soon be a reality for millions of Canadians. Vancouver-based Universal Ibogaine has announced its partnership with Westmount Park Investments to develop addiction…

Researchers Replicate Ketamine Effects By Mimicking Brain Rhythms

Psychedelic-like states of consciousness may soon be achievable without the need for substances like ketamine, psilocybin, or MDMA. A new study, published in the journal Nature, suggests the ability to replicate these altered states of consciousness…

Report on Psychedelics Podcast: October 19 Briefing

Amsterdam Launches the World’s First Public Psilocybin Depression Treatment Program

A groundbreaking depression treatment center has opened in the Netherlands. The Synthesis clinic uses psilocybin to help clients battling depression and other mental health disorders. Psilocybin, which comes from several strains of fungi,…

‘The Hero’s Dose’: Ancient Psychedelic Therapy Gets a Modern Exploration

The idea to write about his quarter-century psychedelic experience had been rolling around in Derek Beres’ head for a while. Perhaps it would be something that would appeal to others who dabble in ‘shrooms or acid. Or maybe it could be…

Conversations: Vine Ventures

How Psychedelics Are Helping Women Beat Breast Cancer

In 2012, author Erica Rex had her first experience with psilocybin. She was three years into a breast cancer diagnosis. Could psychedelics hold the cure? Or at least, part of it? Research is beginning to point to a possible link. Rex volunteered…

Interview with Ember Health

The 2020 Voters Guide to Psychedelic Ballot Measures

There’s a lot at stake this election year November 3rd. Voting by mail has started, and more than 9 million Americans have already mailed in their ballots. Beyond the future of our democracy, there are a few notable ballot measures across…

Can Psychedelics Improve Your Sex Life?

Research into psychedelics shows promise in treating a growing number of ailments including treatment-resistant depression, anxiety, PTSD, and post-operative pain. But it may do you some good in the bedroom, too, according to new scientific…

Conversations: Mert Guler and Angelo Capone, Purves Redmond

How Psychotherapy and Psychedelics Work Together at This Ketamine Center

If you ask Veronika Gold about Polaris Insight Center, the San Francisco-based ketamine-assisted psychotherapy clinic she founded two years ago with a handful of colleagues, she will tell you it is the actualization of a lifelong dream…

Report On Psychedelics Podcast: Endorsement Season

Why Are Psychedelics Illegal?

There was no single moment when all psychedelics became illegal in America. The process took at least four decades to unfold, beginning a year into the Great Depression with the demonization of marijuana. The blueprint created during that effort…

An Art Lover’s Guide Psychedelic Art Plus 3 Artists You Need to Know

Psychedelic art has been around for thousands of years across cultures across the globe. Artists today have transformed the techniques and subject matter in innovative ways. Psychedelic art is defined as the depiction of the inner world of…

This Wearable Ketamine Device Could Be a Breakthrough In Non-Opioid Pain Management

A new wearable ketamine device could help treat pain without the need for habit-forming opioids. Research-stage biotech startup Bexson Biomedical and medical device manufacturer Stevanato Group have partnered on the device. “Post-operative…

Dr. Andrew Weil Joins Advisory Board for Psychedelic Therapy Platform Field Trip

Acclaimed integrative medicine pioneer, Dr. Andrew Weil, has joined the advisory board for psychedelic therapy platform Field Trip Health. “I am extremely pleased to be joining the medical advisory board at Field Trip,” Dr. Weil…

Field Trip Is the Latest Psychedelic Therapy Company to Go Public

Another psychedelic therapy-based company has gone public. Toronto-based Field Trip Health Ltd., which operates the mobile therapy app Trip, is now trading on the Canadian Securities Exchange under the symbol FTRP. Psychedelic therapy for…

Are Psychedelics Putting Oregon On the Brink of a Mental Health Revolution?

For those of us on the outside looking in, it may be hard to imagine how a state as breathtakingly beautiful and progressive as Oregon can be ranked, according to data provided by Mental Health America, as the worst state in the U.S. for…

5-MeO-DMT: Experiencing the Therapeutic God Molecule

Rafael was apprehensive at first. Sitting on a yoga mat facing the setting sun, he whispered to his wife, “I’m scared.” R5-MeO-DMT was a religious experience for Rafael. Recounting his second journey on the outlawed chemical on 5Hive,…

Oregon’s Democratic Party Endorses Legalization of Psilocybin

Oregon’s Democratic Party is telling voters to vote “yes” on psychedelic substances in November. The party has endorsed state ballot measures calling for the legalization of psilocybin mushrooms for therapeutic purposes and the decriminalization…

MindMed and NYU Team Up for $5 Million Psychedelic Research and Training Program

Leading psychedelic biotech company, MindMed, has partnered with NYU’s Langone Health center. Together, they’ll work to develop the NYU Langone Health Psychedelic Medicine Research Training Program. It will lead to a psychedelic research…

Healing Addiction With Psychedelic Therapy

Craig Salerno has seen too much senseless death. “Unfortunately, I can no longer count on my hands how many people I’ve witnessed overdose, die, suicide, and to me, it’s an absolute crisis. Addiction is a crisis and it appears to be on…

Dr. Bronner’s Soap Donates $3 Million to Psychedelic Research and Advocacy

Popular natural soap brand Dr. Bronner’s has launched a campaign to promote psychedelic therapy. ‍ Dubbed the “Heal Soul” campaign, Dr. Bronner’s hopes to draw attention to public education and advocacy work helping make psychedelic-assisted…

New Oregon TV Ad Supports Psilocybin Legalization Ballot Measure

A new television ad is aimed at convincing Oregonians to vote in favor of legislation that will decriminalize psychedelics. The new ad, which most Oregon residents are likely to see close to seven times before election day, is part of a…

How Psychedelics Saved Former NBA Star Lamar Odom From Drug Addiction

In a new documentary about his life, former NBA forward Lamar Odom says the psychedelic drugs ketamine and ibogaine saved him from his drug addiction. He says the drugs saved his life. The film, “Lamar Odom Reborn,” was directed by Mike…

Johns Hopkins Center for Psychedelic & Consciousness Research Interview

https://www.youtube.com/watch?v=oJiDDATv9uU&feature=emb_logo

Ibogaine and LSD Producer MindMed Applies for Nasdaq Up-Listing

Just days after UK-based psychedelic developer Compass Pathways went public, New York-based MindMed has applied for a Nasdaq up-listing. The company, valued at $190 million, is already listed on Canada’s NEO exchange. MindMed…

Taking a Psychedelic Trip? There’s an App for That

There are apps for nearly everything, these days. Now, there’s even an app to guide you through a psychedelic experience. Field Trip Psychedelics Inc., which operates clinics in Toronto, New York, and Los Angeles, has launched Trip,…

Taking Psychedelics Mimics Religious Experiences

New data reveal that taking psychedelics may impact users in a way similar to having a mystical or religious experience. The study, published in The Journal of Psychoactive Drugs, surveyed 288 people about their experiences with psychedelics. The…

Psychedelics and the Search for Self Consciousness

In September of 1848, a group of construction workers were tamping down blasting powder with 3cm thick iron rods when an accident sent a rod through the skull of the foreman, Phineas Gage. The rod entered the roof of his mouth and exited through…

Octopuses On MDMA Want to Snuggle Just Like You

In the Netflix documentary My Octopus Teacher, filmmaker Craig Foster befriends an octopus in the Atlantic waters near his home. Over a year, he visits her nearly every day. Their bond, even though octopuses are solitary animals, becomes…

Compass Pathways IPO Brings $1 Billion Valuation

UK-based Compass Pathways led a groundbreaking IPO last week. Share prices spiked 71 percent to nearly $30 after the initial offering of 7.5 million shares, which launched at $17 each. Current value of the company based on its 34 million shares…

Johns Hopkins to Build World’s Largest Registry on Psilocybin Use

The John Hopkins Center for Psychedelic and Consciousness Research (CPCR) will create the world’s largest registry on psilocybin use, the center announced last month. In a partnership with Unlimited Sciences, a psychedelic research nonprofit,…

Why Investors Are Betting On Psychedelics

While they’ve historically brought the risk of long jail sentences, psychedelics are now bringing another long-term scenario: big-time investments. The potential for psychedelics in treating mental disorders such as depression, suicidal…

Ibogaine Therapy Offers Hope For Opioid Addiction

At his worst, D.F. thought heroin wasn’t his problem. It was his solution. It soothed his physical pain, killed the uncomfortable emotions, and quieted the noise in his head. He began self-medicating with daily doses of heroin, methadone,…

Ann Arbor Michigan Decriminalizes Psychedelics

Ann Arbor Michigan, home to Big 10 college football at the University of Michigan, is now about to become another big designation — the city is taking a substantial stance in favor of psychedelic substances. The Ann Arbor City Council voted…

The Psychedelic Medicine Association Launches to Align the Industry

A first of its kind, The Psychedelic Medicine Association (PMA) is set to launch on September 29th. The association aligns medical establishments, patients, and industry leaders in the advancement of psychedelic therapy. “We want physicians…

The Risks and Rewards of Psychedelic Medicine

“What in the world is going on here? How do we wrap our heads around this?” Dr. Roland Griffiths is asking the question on the minds of many psychiatrists and scientists. Dr. Griffiths is director of the Center for Psychedelic and Consciousness…

Understanding Ayahuasca: Combining Clinical Insights With Personal Experience

The traditional Amazonian psychedelic concoction, Ayahuasca, has begun to receive widespread attention for its powerfully therapeutic benefits. As countless people from across the globe travel to destinations like Mexico and South America to…

New Partnership Will Bring Quick-Dissolve Strips to Psychedelics

Psychedelic drugs could soon have a standardized, and much faster delivery method with the announcement last month that ATAI Life Sciences AG and IntelGenx have entered into an agreement to develop polymeric film technologies. The…

Lauren Taus Brings All Her Strengths to Ketamine Therapy

I left my conversation with Lauren Taus thinking about Henry David Thoreau, the early American essayist, poet and philosopher. Which wasn’t exactly what I had expected. If you Google her name, you will see many images of Lauren in her…

How Psychedelics Helped Riley Cote

For fans of the game of hockey, the only thing more exhilarating than the blare of the goal horn after their team scores is the moment when a player finally takes the bait — after countless minutes of chirping, a few heavy hits, and maybe…

Heroic Hearts Project Connects Military Veterans with Psychedelic Therapy

On an improvised 70-mile marathon through the Andes Mountains of Peru, alone and severely dehydrated, it occurred to Jesse Gould that he might die. A former Army Ranger, Gould knew about pushing himself to the physical limit. Now his experience…

CEO of Canadian Stock Exchange on Psychedelic Investments

Listening to Richard Carleton – the CEO of the Canadian Securities Exchange – talk about future investment opportunities in the psychedelic space, you come away with two thoughts: The differences between cannabis and psychedelics are stark,…

Ketamine: The Greatest Drug in the World?

The wording was key. Use the wrong term or phrase to describe a peculiar experience associated with an experimental drug, and it’s sure to be the old nail in the molecule’s coffin. Find the right words, and you open up a world of pharmacological…

Canadian Manufacturer Licensed to Make Psilocybin

Vancouver-based Mydecine Innovations Group, Inc., has become the first company to earn the license to legally produce and distribute pharmaceutical-grade psilocybin in Canada, the company announced last month. Mydecine, which also has offices…

Could Low Doses of LSD Make Opioids Obsolete?

Better known for its psychedelic properties, Lysergic Acid Diethylamide (LSD) became extremely popular during the counterculture of the 1960’s. But it wasn’t only popular among the free-loving hippies... What most people fail to realize…

Spotlighting Several Remarkable Psilocybin Retreats

To start with, you’re going to need to find your passport. Because psilocybin mushrooms and truffles are illegal in all fifty states, you’ll have to say fairly well to the old US of A for a few days. Ready? I know just the place —…

Psychedelic-Friendly ‘Initiative 81’ Plants Roots in D.C. November Ballot

Each day millions of Americans sit in front of their screens and wonder, what’s next? What more could 2020 possibly have up its sleeve? Fortunately for us shroomies, it’s good news because Washington D.C. is one step closer to potentially…

The Quest For A Market-Friendly Synthetic Psilocybin Is Decades In The Making

Exactly 65 years ago, R. Gordon Wasson, a vice president of J.P. Morgan & Co., leaned over the desk of the highest ranking official in a remote Mexican Indian village high atop the Mixeteco mountains and whispered, “Will you help me learn…

One Ayahuasca Ceremony Might Reset Mental Health

A single experience with the psychedelic South American brew called ayahuasca may help reduce psychopathology and depression in users for up to six months, a new study finds. The findings, published in the recent issue of the journal Scientific…

From Dynamic Entrepreneur to an Advocate Psychedelic Medicine: Tim Ferris

When discussing notable figures that are influencing the emerging psychedelic space, including well-known celebrities and social icons, it’s hard to miss the impact of renowned American entrepreneur, biohacker, author, and podcaster, Tim…

Establishing the Ethical Imperative in Psychedelic Medicine

Psychedelics are making a bold comeback and are poised to revolutionize modern medicine as we currently know it. With MDMA-assisted psychotherapy receiving the coveted “Breakthrough Therapy” designation by the U.S. Food & Drug Administration,…

MAPS Brings In $30 Million to Fund MDMA Research

When the story is written about how psychedelic medicine emerged into the mainstream, there will be a chapter about August of 2020. Because the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) just made history. Earlier…

Paul Stamets Wants to Save Us: Mushrooms, Mycology & Medicine

Paul Stamets is standing on stage at the Exponential Medicine conference dressed in comfortable jeans and an amadou hat. It’s like he was plucked right out of the enchanted forest where he’s wandered for the past 50 years,…

Interested in Becoming a Magic Mushroom Trip Sitter?

Being a good trip sitter isn’t all that different from being a good babysitter. You must be responsible — no fireworks or switchblades around the children — and you must be trustworthy. If you can be both, you’re more than halfway to…

Denver’s ‘Magic’ Mushroom Law: What You Need to Know

Mushrooms are experiencing a renaissance. Or, rather, they’re now prototypes, paving paths as tools for everything from sustainable meat to animal-free leather. Now a few cities are decriminalizing magic mushrooms as psilocybin’s medicinal…

Microdosing Psychedelics Recent Rediscovery

Microdosing Psychedelics: A Recent Rediscovery

James Fadiman begins by asking, “How many of you have never had any psychedelic experience?” He’s speaking to a Science And Nonduality (SAND) conference, a group that assembles scientists, philosophers, sages and mystics to explore…

Can a Compound in ‘Magic’ Mushrooms Cure Social Anxiety?

Social anxiety is a strange mix of fear, discomfort, and apprehension that many people experience in certain social settings. And in the U.S., many can be counted in the millions, as 7.1 percent of us experience it regularly and 12.1…

Growing Psilocybin Mushrooms Isn’t Magic

It’s a weekend in July and I’m sitting outside a Starbucks in Los Angeles to interview a magic mushroom cultivator for Psychedelic Spotlight. It’s been set up by a third party. I don’t know the name of the man I’m about to meet. I’ve…

MMA Star Goes From Hitting People to Healing People

Psychedelic advocacy is filled with all sorts of healers: therapists, PHDs, psychiatrists, shamans and scientists. Also this one guy who can easily choke you unconscious. Ian McCall is a mixed martial artist, a former professional fighter,…

A Servant of the Mushroom Kingdom

The debut commercial featuring Nike’s famous slogan “Just Do It” starred Walt Stack, an 80-year-old marathon runner in San Francisco who ran 17 miles every morning. “People ask me how I keep my teeth from chattering in the wintertime,”…

Gwyneth Paltrow’s Netflix Show Makes Magic Mushrooms Goopy

“The Goop Lab,” is a new Netflix docuseries, inspired by Gwyneth Paltrow’s “modern lifestyle brand” website, Goop. And I’m reviewing it for Psychedelic Spotlight because the first episode is called “The healing Trip” and features…

Can You Heal a Broken Reality with Psilocybin Therapy?

The disease has dogged Steve since he was a teenager. It limited Steve’s ability to function in school and diminished his career opportunities. Over the years the illness torpedoed romances and friendships. Depression is a desolating mood…

‘Have a Good Trip’ is worth the trip